Federal Circuit Splits Decision in Cardiovascular Systems v. Shockwave Medical Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Cardiovascular Systems, Inc. v. Shockwave Medical, Inc. |
| Case Number | 23-1940 (Fed. Cir.) |
| Court | Federal Circuit, District of Columbia circuit region |
| Duration | May 23, 2023 – July 14, 2025 783 days |
| Outcome | Affirmed-in-Part and Reversed-in-Part (Patentability / Invalidity-Cancellation Action) |
| Patents at Issue | |
| Accused Products | Shockwave balloon catheter system |
Case Overview
The Parties
⚖️ Plaintiff
Medical device company focused on peripheral and coronary artery disease treatment, known for its orbital atherectomy platform.
🛡️ Defendant
Prominent developer of intravascular lithotripsy (IVL) technology, whose balloon catheter systems have gained significant commercial traction.
The Patent at Issue
This case centered on **U.S. Patent No. US8956371B2** (Application No. US12/482995), covering technology in the catheter-based cardiovascular intervention space. The patent’s claims relate to structural and functional aspects of balloon catheter systems used in vascular treatment procedures.
Developing similar medical devices?
Check if your catheter or balloon system might infringe this or related patents.
The Verdict & Legal Analysis
Outcome
The Federal Circuit issued an **Affirmed-in-Part and Reversed-in-Part** judgment in *Cardiovascular Systems, Inc. v. Shockwave Medical, Inc.* This split outcome means the appellate court agreed with some lower-level findings while overturning others. Specific damages figures were not disclosed, consistent with patentability-focused proceedings where monetary relief is not the primary remedy sought.
Key Legal Issues
The central legal question was **patentability** — specifically, whether the claims of U.S. Patent No. US8956371B2 should survive validity challenges brought by Shockwave Medical. This type of action typically involves arguments under 35 U.S.C. §§ 102 and 103 (anticipation and obviousness) or § 112 (enablement and written description).
Filing a medical device patent?
Learn from this case. Use AI to draft stronger claims that can withstand validity challenges.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence in the medical device sector.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in medical device development. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications for medical device patent litigation.
- Identify key claim construction patterns
- Analyze prior art strategies in medical device cases
- Explore related patents in cardiovascular technology
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own medical technology or product.
- Input your device description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
Patent Risk Persists
Affirmed claims retain enforceability
Claim Differentiated Outcome
Highlights targeted invalidity effectiveness
Proactive FTO Essential
For new medical device development
✅ Key Takeaways
For Patent Attorneys & Litigators
Split Federal Circuit decisions in patentability appeals reinforce the value of robust, differentiated claim sets during prosecution.
Search related case law →Partial dismissal of appeals on procedural grounds can narrow issues before merits review — early procedural strategy matters.
Explore precedents →For IP Professionals
Monitor surviving claims of US8956371B2 for ongoing licensing and enforcement risk in catheter-based cardiovascular product lines.
Start FTO analysis for my product →Mixed patentability outcomes signal opportunities for continuation prosecution to fortify enforceable claim scope.
Try AI patent drafting →For R&D Teams
Conduct updated FTO analyses against affirmed claims before advancing competing balloon catheter or IVL product development.
Run FTO analysis for my device →This case underscores that IP risk in medical devices persists even after partial appellate victories.
Learn more about medical device IP →Cases & Resources to Watch
Review related Federal Circuit decisions on medical device patentability at the Federal Circuit’s official case database →
Search U.S. Patent No. US8956371B2 on USPTO Patent Full-Text Database →
Monitor Case No. 23-1940 filings via PACER →
Ready to Strengthen Your Medical Device Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes in the medtech industry.